相关实验视频

Updated: May 27, 2025

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

雪松病毒生物学及其作为高度致病性海尼帕病毒的替代品的应用

Ahmad Jawad Sabir¹, Lijun Rong¹, Christopher C Broder²

¹Department of Microbiology and Immunology, University of Illinois College of Medicine, Chicago, IL, 60612, USA.

|February 19, 2025

概括

雪松病毒 (CedV) 是一种非致病性海尼帕病毒,为研究海尼帕病毒感染提供了一个安全的模型. 使用CedV的研究有助于开发对抗高度毒性的尼帕病毒 (NiV) 和亨德拉病毒 (HeV) 的对策.

科学领域:

病毒学病毒学
传染性疾病传染性疾病
公共卫生公共卫生

背景情况:

尼帕病毒 (NiV) 和亨德拉病毒 (HeV) 是高度致病的亨尼病毒,导致致命的动物性传染病.
这些BSL-4病原体具有显著的跨境威胁,没有批准的人类治疗方法.
世界卫生组织将海尼帕病毒确定为优先病原体,需要紧急研究.

研究的目的:

审查Cedar病毒 (CedV) 的独特生物学,这是唯一的非致病性henipavirus.
探索CedV如何成为研究病毒与宿主相互作用的有价值模型.
突出CedV在促进针对毒性海尼帕病毒的治疗策略的开发中的作用.

主要方法:

审查现有的科学文献关于henipavirus生物学和对策的发展.
分析CedV的非致病特征及其对研究的影响.
探索CedV在BSL-2封闭环境中的实用性,以研究henipavirus.

主要成果:

由于CedV的非致病性,因此可以对病毒机制进行更安全的研究.
在较低的生物安全制水平 (BSL-2) 上,CedV促进了对病毒与宿主相互作用的研究.
使用CedV作为模型加速了对NiV和HeV的对策研究.

结论:

雪松病毒代表了推动海尼帕病毒研究的关键工具.
CedV使得开发有效的预防和治疗策略,以对抗严重的henipaviral疾病.
进一步利用CedV的研究对于减轻海尼帕病毒对全球健康的威胁至关重要.

关键词:

抗病毒疗法抗病毒疗法雪松树病毒病毒新出现的病毒病毒.黑尼帕病毒病毒.没有致病性.

更多相关视频

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Published on: January 15, 2020

相关概念视频

Viral Recombination

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...